Xenical Causal Link To Breast Neoplasm Cannot Be Ruled Out - FDA
Executive Summary
An additional clinical trial of Roche's anti-obesity agent Xenical would be needed to rule out a causal link between the drug and breast cancer, FDA Epidemiologist Bruce Stadel, MD, told the Endocrinologic & Metabolic Drugs Advisory Committee March 13.